Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of Bio-Reference Laboratories, Inc. (“Bio-Reference” or the “Company”) (NASDAQ:BRLI) related to the proposed acquisition of the Company by OPKO Health, Inc. (“OPKO”) (NYSE:OPK). The transaction is valued at approximately $1.47 billion and under the terms of the agreement, Bio-Reference shareholders are to receive 2.75 shares of OPKO for each Bio-Reference share they own.

This investigation concerns whether the Board of Directors of Bio-Reference breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction.

If you are a shareholder of Bio-Reference, if you have information or would like to learn more about our investigation, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150608006319/en/